Thiazole pyrazolopyrimidines CRF1 receptor antagonists
US8030304B2 · kind B2 · utility
16Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2007 |
| Grant date | Oct 4, 2011 |
| Priority date | — |
| Expiry date | Jun 30, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula (I), pharmaceutical compositions thereof, and use thereof as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric and neuroendocrine disorders, neurological diseases, and metabolic syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.